Table 3. Comparison of coronary calcification (CAC score—AU) in the statin and control groups, considering calcified (≥ 10 AU), non-calcified and all patients.
| Control | Statin | Between groups | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 12 months | Delta | P | Baseline | 12 months | Delta | P | PT0 | PT12 | |
| Calcified patients* | 228 (70–900) | 248 (105–1200) | 13.0 (-5–31) | 0.10 | 182 (18–290) | 181 (57–330) | 24 (-12–66) | 0.25 | 0.42 | 0.23 |
| 562.9 ± 718.6 | 647.0 ± 727.8 | 15.1 ± 27.8 | 358 ± 662.4 | 390.4 ± 763.9 | 59.0 ± 119.4 | |||||
| Non-Calcified patients** | 0 (0–3) | 0 (0–7) | 0 (0–4) | 0.02 | 0 (0–24) | 0 (0–8) | 0 (-16–0) | 0.16 | 0.50 | 0.87 |
| 0.1 ± 0.5 | 0.5 ± 1.5 | 0.4 ± 1.0 | 1.0 ± 4.4 | 0.6 ± 1.6 | -0.4 ± 1.8 | |||||
| All patients | 0 (0–77) | 0 (0–123) | 0 (0–0) | 0.06 | 0 (0–74) | 1 (0–96) | 0 (0–23) | 0.14 | 0.29 | 0.44 |
| 183.9 ± 482.1 | 211.6 ± 509.3 | 19.6 ± 74.0 | 148.1 ± 455.0 | 161.1 ± 520.5 | 24.8 ± 85.4 | |||||
*N = 33 patients (13 in control and 20 in statin group).
** N = 67 patients(36 in control and 31 in statin group).
Mean ± standard deviation, median (interquartile).